Core Viewpoint - Jamf Holding Corp. is under investigation for potential breaches of fiduciary duties by its board of directors in relation to a proposed take-private sale at $13.05 per share, which may be considered an unfairly low price for shareholders [1][3]. Group 1: Investigation Details - The investigation is led by Bleichmar Fonti & Auld LLP, focusing on whether Jamf's board and Vista Equity Partners have acted in the best interests of shareholders regarding the acquisition by Francisco Partners Management, L.P. [5][3]. - Jamf's board did not form an independent special committee to assess the acquisition, raising concerns about conflicts of interest, particularly since Vista owns 34.4% of Jamf's stock and has the right to appoint four board members [4][3]. Group 2: Shareholder Implications - Current shareholders of Jamf are encouraged to seek additional information and may have legal options available to them regarding the proposed transaction [2][6]. - The acquisition is contingent upon a stockholder vote, but Vista's participation in that vote has not been excluded, which could further complicate the situation for shareholders [4][3].

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Edwards Lifesciences Corporation, urging shareholders to contact the firm to discuss their rights [1][2]. Group 1: Shareholder Rights and Legal Options - Long-term shareholders of Edwards Lifesciences may seek corporate governance reforms, return of funds, court-approved financial incentives, or other benefits [2]. - Shareholder involvement is emphasized as a means to improve company policies and enhance shareholder value through better oversight and accountability [3]. Group 2: Firm's Background and Experience - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors [4].